To be a leader in the field of NMR metabolomics, offering high-quality services and innovative solutions to understand and analyze metabolic profiles accurately and efficiently.
Our vision is to drive significant advances in biomedical research and personalized medicine by providing valuable and insightful information to improve human health and global well-being. We strive to be recognized as a trusted partner and expert in NMR metabolomics, contributing to scientific advancement and providing solutions that have a positive impact on society.
Our team has more than 100 publications in leading scientific journals worldwide.
Abstract Background: Triglyceride-rich lipoproteins (TRLs) can have an important role in atherosclerosis development due to their size and ability to …
Abstract Background: Obesity is related to cardiovascular risk factors (CVRF) such as dyslipidemia, diabetes, and hypertension, which increase mortality. Basic lipid …
Abstract Background and aims: We aimed to assess the associations of exposure to air pollutants and standard and advanced lipoprotein measures, …
Abstract Fetal growth restriction (FGR) affects 5-10% of pregnancies, is the largest contributor to fetal death, and can have long-term …
Abstract Background and aim: Circulating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those …
Abstract Minimally invasive prognostic markers of inflammation and dyslipidemia in individuals with a risk of psychosis, also called “at-risk mental …
Abstract Aims: The aim of this study was to combine nuclear magnetic resonance-based metabolomics and machine learning to find a glucose-independent …
Abstract Primary hypocholesterolemia (or hypobetalipoproteinemia) is a rare disorder of lipoprotein metabolism that may be due to a polygenic predisposition …
Abstract The progressive forms of multiple sclerosis (MS) primary progressive MS (PPMS) and secondary progressive MS (SPMS) are clinically distinguished …
Abstract Atherosclerosis is a chronic inflammatory disease caused by the accumulation of cholesterol in the intima. Proprotein convertase subtilisin/kexin type …
